Starting With Combination Diabetes Therapy Beats Initial MonotherapyJune 2, 2016DiabetesEndocrinology
Initial Monotherapy Safe in Type 2 Diabetes but Must Be Abandoned Quickly if IneffectiveMay 27, 2016DiabetesEndocrinology
Diabetic Foot Ulcers Linked to Cognitive DeclineMay 19, 2016DermatologyDiabetesEndocrinologyNeurology
FDA Alert: Canagliflozin Use May Be Associated With Toe, Foot AmputationsMay 18, 2016DiabetesEndocrinology
No Rise in Serious HF Seen in Patients Taking Saxagliptin or SitagliptinApril 25, 2016EndocrinologyCardiologyDiabetes
T2DM Patients on Combination Therapy Benefit in Switch From Sitagliptin to LiraglutideApril 10, 2016DiabetesEndocrinology
Early Predictors of GDM Identified in Women With PCOSApril 10, 2016DiabetesEndocrinologyWomen's Health
Incretin-based Diabetes Drugs Don’t Raise Heart Failure RiskMarch 23, 2016DiabetesEndocrinologyCardiology
